Ibex LTD Form 4 insider transactions

IBEX Ltd's Chief Executive Officer, Robert Thomas Dechant, reported the sale of 15,000 common shares on June 13, 2025, executed under a Rule 10b5-1 trading plan.

Mohammedulla Khaishgi, a Director at IBEX Ltd, has sold a total of 70,000 common shares over two days in June 2025, significantly reducing his direct beneficial ownership.

IBEX Ltd. Director Patrick McGinnis reported the sale of 220 common shares at $30 per share, reducing his direct beneficial ownership to 4,780 shares, executed under a Rule 10b5-1 plan.

Paul Joseph Inson, Chief People Officer of IBEX Ltd, has reported the sale of 3,690 common shares at a price of $28.59 per share, executed under a Rule 10b5-1 trading plan.

Bruce Neil Dawson, Chief Sales and CS Officer of IBEX Ltd., exercised stock options and sold shares on March 5, 2025.

IBEX Ltd CEO Robert Thomas Dechant exercised stock options and sold shares on February 26, 2025, resulting in a change in his beneficial ownership.

Director Mohammedulla Khaishgi sold 12,600 shares of Ibex Ltd on February 21, 2025, at an average price of $25.5744.

Director Mohammedulla Khaishgi reported selling common shares of Ibex Ltd in multiple transactions on February 19 and 20, 2025.

Director Mohammedulla Khaishgi sold shares of Ibex Ltd on February 18, 2025, according to a Form 4 filing.

Julie K. Casteel, Chief Sales/Marketing Officer of Ibex Ltd, exercised stock options and sold shares on February 14, 2025, resulting in changes to her beneficial ownership.

Director Karen Batungbacal acquired 5,000 restricted stock units in Ibex Ltd on February 14, 2025, according to a Form 4 filing.

Director Zhuang Mingzhe reports acquisition of 5,000 common shares and restricted stock units in Ibex Ltd.

Director Patrick McGinnis acquired 5,000 common shares of IBEX Ltd on February 14, 2025, through the grant of Restricted Stock Units (RSUs).

Director Mohammedulla Khaishgi of Ibex Ltd. reports selling common shares in multiple transactions on February 13 and 14, 2025.

IBEX Ltd.'s CEO, Robert Thomas Dechant, sold 5,000 common shares at an average price of $27.5552 on February 14, 2025.

Paul Joseph Inson, Chief People Officer of IBEX Ltd, sold 8,954 common shares on February 14, 2025, at a weighted average price of $27.5318.

Chief People Officer Paul Joseph Inson of Ibex Ltd. reports exercising stock options and selling shares on February 11, 2025.

Chief People Officer of IBEX Ltd., Paul Joseph Inson, sold 8,044 common shares at an average price of $25.0028 on February 11, 2025.

Christina Alice Trofimuk-O'Connor, Chief Legal Officer of IBEX Ltd, reports the acquisition and disposal of common shares and stock options on February 12, 2025.

Christina Alice Trofimuk-O'Connor, Chief Legal Officer of IBEX Ltd., reports exercising stock options and selling shares on February 11, 2025.

IBEX Ltd CEO Robert Thomas Dechant sold a portion of his IBEX shares in transactions on February 10th and 11th, 2025.

Director Mohammedulla Khaishgi of Ibex Ltd reports selling common shares in a series of transactions between February 10 and February 12, 2025.

Chief People Officer of IBEX Ltd., Paul Joseph Inson, sold 1,956 common shares of the company on February 7, 2025, at a weighted average price of $25.0019.

Bruce Neil Dawson, Chief Sales and CS Officer of IBEX Ltd, sold 13,500 common shares of the company on February 7, 2025, at a price of $24 per share.

Director Mohammedulla Khaishgi sold shares of Ibex Ltd. on February 7, 2025.

IBEX Ltd's CEO, Robert Thomas Dechant, sold 2,621 common shares of the company at an average price of $25.0015 on February 7, 2025.

A director of Ibex Ltd, Mohammedulla Khaishgi, sold a significant number of common shares in multiple transactions over two days.

CEO Robert Dechant of IBEX Ltd. reports selling a portion of his holdings in company stock.

A director of Ibex Ltd, Mohammedulla Khaishgi, sold a total of 10,842 common shares in multiple transactions on January 24th and 27th, 2025.

Director Mohammedulla Khaishgi reported the sale of Ibex Ltd common shares on January 21, 2025, according to a Form 4 filing.